Journal of Kerman University of Medical Sciences

Current Issue

By Issue

By Author

Author Index

Keyword Index

About Journal

Aims and Scope

JKMU Ethical Policies

Indexing and Abstracting

Related Links

FAQ

Peer Review Process

News

Metric

Editorial Policies

Data Sharing Policy

The Relationship of Metabolic Syndrome and its Components with Breast Density

Document Type : Original Article

Authors

1 Radiology resident at Shahid Beheshti University of Medical Sciences, Tehran, Iran

2 Department of Radiology, Mahdiye hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Abstract

Background: Breast cancer is a major health problem in Iran with increasing incidence in the recent years. Breast density is one of the most important risk factors for developing breast cancer. Metabolic syndrome that is defined by the presence of multiple clinical and lab data findings has also been shown to be related with breast cancer.
Methods: A sample of 246 cases who referred to Mahdiyeh hospital in Tehran were selected according to the inclusion criteria and a form was prepared including breast density in the screening mammogram done in our center and recent lab tests including FBS, HDL and TG. We also measured the waist circumference, height, weight and blood pressure of all subjects. Data analysis was done through SPSS23 and using fishers exact and ordinal regression tests.
Results: The incidence of metabolic syndrome was 44% among the cases in this study. Mean age ± standard deviation (SD) was 48.08 ± 7.6 years. There was a significant association between lower breast densities and ages greater than 50 years (p = 0.0). There was no significant association between metabolic syndrome or its components and breast density among the patients above 50 years of age but in ages lower than 50 years, there was a significant association between increased breast density and lower abdominal circumference (p=0.017), lower triglyceride levels (p=0.02), higher HDL levels (p=0.018), lower FBS levels and lower frequency of metabolic syndrome.
Conclusion: There was no significant association between metabolic syndrome or its components and mammographic breast density after adjustment for age and BMI.

Keywords

References
  1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin 2019; 69(1):7-34. doi: 10.3322/caac.21551..
  2. Nafissi N, Khayamzadeh M, Zeinali Z, Pazooki D, Hosseini M, Akbari ME. Epidemiology and histopathology of breast cancer in Iran versus other Middle Eastern countries. Middle East J Cancer 2018; 9(3):243-51. doi: 10.30476/mejc.2018.42130.
  3. Tabár L, Vitak B, Chen HH, Duffy SW, Yen MF, Chiang CF, et al. The Swedish Two-County Trial twenty years later: updated mortality results and new insights from long-term follow-up. Radiol Clin North Am 2000; 38(4):625-51. doi: 10.1016/s0033-8389(05)70191-3.
  4. Humphrey LL, Helfand M, Chan BK, Woolf SH. Breast cancer screening: a summary of the evidence for the US Preventive Services Task Force. Ann Intern Med 2002; 137(5 Part 1):347-60. doi: 10.7326/0003-4819-137-5_part_1-200209030-00012.
  5. Moolgavkar SH, Day NE, Stevens RG. Two-stage model for carcinogenesis: epidemiology of breast cancer in females. J Natl Cancer Inst 1980; 65(3):559-69.
  6. Colditz GA, Rosner B. Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the Nurses’ Health Study. Am J Epidemiol 2000; 152(10):950-64. doi: 10.1093/aje/152.10.950.
  7. Rojas K, Stuckey A. Breast cancer epidemiology and risk factors. Clin Obstet Gynecol 2016; 59(4):651-72. doi: 10.1097/GRF.0000000000000239.
  8. Carney PA, Miglioretti DL, Yankaskas BC, Kerlikowske K, Rosenberg R, Rutter CM, et al. Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med 2003; 138(3):168-75. doi: 10.7326/0003-4819-138-3-200302040-00008.
  9. Boyd NF, Byng JW, Jong RA, Fishell EK, Little LE, Miller AB, et al. Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. J Natl Cancer Inst 1995; 87(9):670-5. doi: 10.1093/jnci/87.9.670.
  10. Boyd N, Martin L, Gunasekara A, Melnichouk O, Maudsley G, Peressotti C, et al. Mammographic density and breast cancer risk: evaluation of a novel method of measuring breast tissue volumes. Cancer Epidemiol Biomarkers Prev 2009; 18(6):1754-62. doi: 10.1158/1055-9965.EPI-09-0107.
  11. McCormack VA, dos Santos Silva I. Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2006; 15(6):1159-69. doi: 10.1158/1055-9965.EPI-06-0034.
  12. Bernstein L, Ross RK. Endogenous hormones and breast cancer risk. Epidemiol Rev 1993; 15(1):48-65. doi: 10.1093/oxfordjournals.epirev.a036116.
  13. Lilienfeld AM. The relationship of cancer of the female breast to artificial menopause and marital status. Cancer 1956; 9(5):927-34. doi: 10.1002/1097-0142(195609/10)9:5<927::aid-cncr2820090510>3.0.co;2-3.
  14. Rosner B, Colditz GA, Willett WC. Reproductive risk factors in a prospective study of breast cancer: the Nurses’ Health Study. Am J Epidemiol 1994; 139(8):819-35. doi: 10.1093/oxfordjournals.aje.a117079.
  15. Aiello EJ, Buist DS, White E, Porter PL. Association between mammographic breast density and breast cancer tumor characteristics. Cancer Epidemiol Biomarkers Prev 2005; 14(3):662-8. doi: 10.1158/1055-9965.EPI-04-0327.
  16. Sala E, Solomon L, Warren R, McCann J, Duffy S, Luben R, et al. Size, node status and grade of breast tumours: association with mammographic parenchymal patterns. Eur Radiol 2000; 10(1):157-61. doi: 10.1007/s003300050025.
  17. Roubidoux MA, Bailey JE, Wray LA, Helvie MA. Invasive cancers detected after breast cancer screening yielded a negative result: relationship of mammographic density to tumor prognostic factors. Radiology 2004; 230(1):42-8. doi: 10.1148/radiol.2301020589.
  18. Kerlikowske K, Zhu W, Hubbard RA, Geller B, Dittus K, Braithwaite D, et al. Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy. JAMA Intern Med 2013; 173(9):807-16. doi: 10.1001/jamainternmed.2013.307.
  19. Duffy SW, Tabar L, Smith RA, Krusemo UB, Prevost TC, Chen TH. Risk of breast cancer and risks with breast cancer: the relationship of histologic type with epidemiology, disease progression and survival. Seminars in Breast Disease 1999; 2: 292-300.
  20. Leconte I, Feger C, Galant C, Berlière M, Berg B Vande, D’Hoore W, et al. Mammography and subsequent whole-breast sonography of nonpalpable breast cancers: the importance of radiologic breast density. AJR Am J Roentgenol 2003; 180(6):1675-9. doi: 10.2214/ajr.180.6.1801675.
  21. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120(16):1640-5. doi: 10.1161/CIRCULATIONAHA.109.192644.
  22. Esposito K, Chiodini P, Capuano A, Bellastella G, Maiorino MI, Rafaniello C, et al. Metabolic syndrome and postmenopausal breast cancer: systematic review and meta-analysis. Menopause 2013; 20(12):1301-9. doi: 10.1097/GME.0b013e31828ce95d.
  23. Esposito K, Chiodini P, Colao A, Lenzi A, Giugliano D. Metabolic syndrome and risk of cancer: a systematic review and meta-analysis. Diabetes Care 2012; 35(11):2402-11. doi: 10.2337/dc12-0336.
  24. Alizade Z, Azadbakht L. Review of epidemiology of metabolic syndrome in iran. Iran J Diabetes Metab 2016; 15(3):143-57. [In Persian].
  25. Conroy SM, Butler LM, Harvey D, Gold EB, Sternfeld B, Greendale GA, et al. Metabolic syndrome and mammographic density: the Study of Women’s Health Across the Nation. Int J cancer 2011; 129(7):1699-707. doi: 10.1002/ijc.25790.
  26. Rice MS, Biessy C, Lajous M, Bertrand KA, Tamimi RM, Torres-Mejía G, et al. Metabolic syndrome and mammographic density in Mexican women. Cancer Prev Res (Phila) 2013; 6(7):701-10. doi: 10.1158/1940-6207.CAPR-12-0475.
  27. Kim BK, Chang Y, Ahn J, Jung HS, Kim CW, Yun KE, et al. Metabolic syndrome, insulin resistance, and mammographic density in pre-and postmenopausal women. Breast Cancer Res Treat 2015; 153(2):425-34. doi: 10.1007/s10549-015-3544-7.
  28. Tehranifar P, Protacio A, Schmitt KM, Desperito E, Oskar S, Potter AJ, et al. The metabolic syndrome and mammographic breast density in a racially diverse and predominantly immigrant sample of women. Cancer Causes Control 2015; 26(10):1393-403. doi: 10.1007/s10552-015-0630-4.
  29. Woolcott CG, Courneya KS, Boyd NF, Yaffe MJ, McTiernan A, Brant R, et al. Association between sex hormones, glucose homeostasis, adipokines, and inflammatory markers and mammographic density among postmenopausal women. Breast Cancer Res Treat 2013; 139(1):255-65. doi: 10.1007/s10549-013-2534-x.
  30. Borugian MJ, Spinelli JJ, Gordon PB, Abanto Z, Brooks-Wilson A, Pollak MN, et al. Fasting insulin and endogenous hormones in relation to premenopausal breast density (Canada). Cancer Causes Control 2014; 25(3):385-94. doi: 10.1007/s10552-014-0339-9.
  31. Furberg AS, Veierød MB, Wilsgaard T, Bernstein L, Thune I. Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk. J Natl Cancer Inst 2004; 96(15):1152-60. doi: 10.1093/jnci/djh216.
  32. Agnoli C, Berrino F, Abagnato CA, Muti P, Panico S, Crosignani P, et al. Metabolic syndrome and postmenopausal breast cancer in the ORDET cohort: a nested case--control study. Nutr Metab Cardiovasc Dis 2010; 20(1):41-8. doi: 10.1016/j.numecd.2009.02.006.
  33. Furberg AS, Jasienska G, Bjurstam N, Torjesen PA, Emaus A, Lipson SF, et al. Metabolic and hormonal profiles: HDL cholesterol as a plausible biomarker of breast cancer risk. The Norwegian EBBA Study. Cancer Epidemiol Biomarkers Prev 2005; 14(1):33-40.
  34. Sung J, Song YM, Stone J, Lee K, Kim SY. High-density lipoprotein cholesterol, obesity, and mammographic density in Korean women: the Healthy Twin study. J Epidemiol 2011; 21(1):52-60. doi: 10.2188/jea.je20100078.
  35. Tamburrini AL, Woolcott CG, Boyd NF, Yaffe MJ, Terry T, Yasui Y, et al. Associations between mammographic density and serum and dietary cholesterol. Breast Cancer Res Treat 2011; 125(1):181-9. doi: 10.1007/s10549-010-0927-7.
  36. Aiello EJ, Tworoger SS, Yasui Y, Stanczyk FZ, Potter J, Ulrich CM, et al. Associations among circulating sex hormones, insulin-like growth factor, lipids, and mammographic density in postmenopausal women. Cancer Epidemiol Biomarkers Prev 2005; 14(6):1411-7. doi: 10.1158/1055-9965.EPI-04-0920.

 

Journal of Kerman University of Medical Sciences
Volume 28, Issue 6
November and December 2021
Pages 589-594
Files
Share
How to cite
Statistics